Hongchang International Co., Ltd (HCIL)
About Hongchang International Co., Ltd
HONGCHANG INTRNATIONAL CP
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $2.9M
- Net income
- -$378.8K
- Total assets
- $57.5M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Hongchang International Co., Ltd (HCIL) Stock Price
- Reported a net loss of $378.8K in FY2024.
- Trading 50% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Hongchang International Co., Ltd.
Write a review
Hongchang International Co., Ltd: frequently asked questions
Is Hongchang International Co., Ltd an American company?
Hongchang International Co., Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Hongchang International Co., Ltd publicly traded?
Yes — Hongchang International Co., Ltd is a publicly traded company. Its stock trades under the ticker symbol HCIL on the OTC.
What does Hongchang International Co., Ltd do?
Hongchang International Co., Ltd is an American Medical Devices company in the Health & Beauty sector.
